NCT01507714

Brief Summary

Urinary stress incontinence is defined as leakage of urine during stress. Urinary stress incontinence is a health problem with social, economic and psychological consequences. The appearance of Urinary stress incontinence post vaginal wall prolapse repair is a known phenomena. Part of the cases relate to pre-surgical occult Urinary stress incontinence which has been asymptomatic, and part of the cases relate to de-novo urinary stress incontinence post surgery. Latest studies have demonstrated 11-22% rate of post surgical urinary stress incontinence. The aim of this study is to examine the efficacy of transobturator tension free vaginal tape (TVT-O) among women who intend to undergo vaginal wall repair by a vaginal approach.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 2, 2012

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 11, 2012

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 11, 2012

Status Verified

January 1, 2012

Enrollment Period

2 years

First QC Date

January 2, 2012

Last Update Submit

January 8, 2012

Conditions

Keywords

Preventivetvt-ostress incontinence

Outcome Measures

Primary Outcomes (1)

  • Stress incontinence

    The women will be classified as continent or not continent according to: * the Pelvic Floor Distress Inventory * stress test * need to other treatment for stress incontinence

    One year post operation

Secondary Outcomes (2)

  • Surgical complications

    one year

  • post surgery urgency or urge incontinence

    one year

Study Arms (2)

control arm

NO INTERVENTION

vaginal wall repair surgery will be done to women in this arm, with no treatment for stress incontinence

TVT-O arm

ACTIVE COMPARATOR

the women in this arm will have a TVT-O procedure in addition to the vaginal wall repair

Procedure: Preventive transobturator tension free vaginal tape

Interventions

during the vaginal wall repair surgery, a TVT-O procedure will be done

Also known as: GYNECARE TVT™ Obturator System
TVT-O arm

Eligibility Criteria

Age30 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women with vaginal wall prolapse grade 2 and more
  • no contraindication to vaginal wall repair or tvt-o
  • No stress incontinence

You may not qualify if:

  • urinary tract malformations
  • past urinary stress incontinence surgical procedure
  • UDI - question 17 or 18 - positive answer
  • Occult urinary stress incontinence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep of OG/GYN, Emek Medical Center

Afula, Israel

Location

MeSH Terms

Conditions

Pelvic Organ ProlapseUrinary Incontinence, Stress

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and Symptoms

Study Officials

  • MEIRAV BRAVERMAN, MD

    HaEmek Medical Center, Afula, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2012

First Posted

January 11, 2012

Study Start

January 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

January 11, 2012

Record last verified: 2012-01

Locations